Alex Gorsky - Johnson Johnson Chairman
JNJ Stock | USD 149.27 0.65 0.43% |
Chairman
Mr. Alex Gorsky is Chairman of the Board, Chief Executive Officer of Directors of the Company. He was appointed as Chairman, Board of Directors in December 2012. He was named Chief Executive Officer, Chairman of the Executive Committee and joined the Board of Directors in April 2012. Mr. Gorsky began his Johnson Johnson career with Janssen Pharmaceutica Inc. in 1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management. In 2001, Mr. Gorsky was appointed President of Janssen Pharmaceutical Inc., and in 2003 he was named Company Group Chairman of the Johnson Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson Johnson in 2004 to join Novartis Pharmaceuticals Corporationrationration, where he served as head of the companys pharmaceutical business in North America. Mr. Gorsky returned to Johnson Johnson in 2008 as Company Group Chairman for Ethicon. In early 2009, he was appointed Worldwide Chairman of the Surgical Care Group and member of the Executive Committee. In September 2009, he was appointed Worldwide Chairman of the Medical Devices and Diagnostics Group. Mr. Gorsky became Vice Chairman of the Executive Committee in January 2011. Mr. Gorsky also serves on the boards of the Travis Manion Foundation, the Congressional Medal of Honor Foundation, the National Academy Foundation, and the Wharton Board of Overseers. He is also a member of the Board of Directors of the Business Roundtable and serves as the Chairman of its Corporationrationrate Governance Committee. since 2022.
Age | 64 |
Tenure | 2 years |
Address | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
Phone | 732 524 0400 |
Web | https://www.jnj.com |
Johnson Johnson Management Efficiency
The company has Return on Asset of 0.0801 % which means that on every $100 spent on assets, it made $0.0801 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2424 %, implying that it generated $0.2424 on every 100 dollars invested. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Johnson Johnson's Return On Tangible Assets are relatively stable compared to the past year. Return On Capital Employed is expected to hike to 0.26 this year, although the value of Return On Assets will most likely fall to 0.14. At this time, Johnson Johnson's Total Current Liabilities is relatively stable compared to the past year. Liabilities And Stockholders Equity is expected to hike to about 175.9 B this year, although the value of Change To Liabilities is projected to rise to (962.5 M).Similar Executives
Found 9 records | CHAIRMAN Age | ||
Robert JD | Merck Company | 57 | |
Kenneth Frazier | Merck Company | 67 | |
Giovanni Caforio | Bristol Myers Squibb | 56 | |
Richard Gonzalez | AbbVie Inc | 70 | |
Carlos Alban | AbbVie Inc | 55 | |
Albert DVM | Pfizer Inc | 62 | |
Robert Bradway | Amgen Inc | 61 | |
Daniel ODay | Gilead Sciences | 60 | |
Robert Michael | AbbVie Inc | 54 |
Management Performance
Return On Equity | 0.24 | ||||
Return On Asset | 0.0801 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
A Washington, Independent Director | ||
Dirk Brinckman, Chief Officer | ||
Jennifer Doudna, Independent Director | ||
Alex Gorsky, Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee | ||
Michael Sneed, Executive Vice President - Global Corporate Affairs and Chief Communication Officer | ||
Marillyn Hewson, Independent Director | ||
Duane Arsdale, Treasurer | ||
Michael Ullmann, VP, General Counsel and Member of Executive Committee | ||
Jasmina Brooks, President Webster | ||
Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
Joseph CPA, Executive CFO | ||
Michael Bodner, Global Recovery | ||
Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
Mary Beckerle, Independent Director | ||
Nadja West, Independent Director | ||
Mark Larkins, Worldwide Secretary | ||
Darius Adamczyk, Independent Director | ||
Vanessa Broadhurst, Executive Vice President Global Corporate Affairs | ||
Hani Abouhalka, Company Digital | ||
Ahmet Tezel, Group RD | ||
Robert Decker, Controller Officer | ||
Ashley McEvoy, Executive Vice President - Worldwide Chairman, Medical Devices | ||
Mathai Mammen, Executive Vice President Pharmaceuticals, R&D | ||
Timothy Schmid, Executive MedTech | ||
Ronald Williams, Independent Director | ||
Tom Cavanaugh, Company Medicine | ||
Kathryn Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
William Hait, Executive Vice President Chief External Innovation, Medical Safety, Global Public Health Officer | ||
James Swanson, Executive Vice President, Chief Information Officer | ||
D Davis, Independent Director | ||
Hubert Joly, Independent Director | ||
Anne Mulcahy, Lead Independent Director | ||
Joseph Wolk, Chief Financial Officer, Executive Vice President | ||
Thibaut Mongon, Executive Vice President, Worldwide Chairman, Consumer Health | ||
Jessica Moore, Vice Relations | ||
Ian Davis, Independent Director | ||
Paulus Stoffels, Worldwide Chairman of Pharmaceuticals, Chief Scientific Officer and Member of Executive Committee | ||
Mark McClellan, Independent Director | ||
Charles Prince, Independent Director | ||
Celine Martin, Group CSS | ||
Elizabeth Forminard, Executive Counsel | ||
Peter Fasolo, Chief Human Resource Officer, Executive Vice President | ||
Guy MD, Group EMEA | ||
Mark Weinberger, Independent Director |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.24 | ||||
Return On Asset | 0.0801 | ||||
Profit Margin | 0.45 % | ||||
Operating Margin | 0.29 % | ||||
Current Valuation | 366.66 B | ||||
Shares Outstanding | 2.41 B | ||||
Shares Owned By Institutions | 71.25 % | ||||
Number Of Shares Shorted | 16.56 M | ||||
Price To Earning | 24.69 X | ||||
Price To Book | 5.17 X |
Johnson Johnson Investors Sentiment
The influence of Johnson Johnson's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Johnson. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Johnson Johnson's public news can be used to forecast risks associated with an investment in Johnson. The trend in average sentiment can be used to explain how an investor holding Johnson can time the market purely based on public headlines and social activities around Johnson Johnson. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Johnson Johnson's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Johnson Johnson's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Johnson Johnson's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Johnson Johnson.
Johnson Johnson Implied Volatility | 17.91 |
Johnson Johnson's implied volatility exposes the market's sentiment of Johnson Johnson stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Johnson Johnson's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Johnson Johnson stock will not fluctuate a lot when Johnson Johnson's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Johnson Johnson in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Johnson Johnson's short interest history, or implied volatility extrapolated from Johnson Johnson options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Johnson Johnson's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.106 | Dividend Share 4.76 | Earnings Share 6.73 | Revenue Per Share 34.477 | Quarterly Revenue Growth 0.023 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.